drugset / Trial / NCT06177535

A Study of Oral Kavalactones Effect on Nurses

NCT06177535 ↗

Active not recruiting 200 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindSupportive care

Summary

This research study is being done to assess the impact of taking Kava extract (Piper methysticum), a dietary supplement on cortisol in a healthy nursing population.

Timeline

Start
2024-08-05
Primary completion
2026-09-30
Completion
2026-11-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Kavalactones Unknown 225 mg Oral

Indications

No indication recorded.